Apexigen, Inc.

Patents = 14

Trademarks = 1

Forward Citations = 56

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

17 inventors (with patents filed for the assignee):

Apexigen is a clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough antibody-based therapeutics for the treatment of life-threatening diseases. With a focus on oncology, Apexigen utilizes their proprietary antibody technology platform to create next-generation antibody therapeutics that target specific disease pathways. By leveraging their expertise in antibody discovery, optimization, and engineering, Apexigen aims to deliver innovative treatments that improve patient outcomes and address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com